Keresty Georgia (CIK 1773532) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-10). Recent activity: Buy NTLA (9,200 shares), Buy NTLA (8,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-10 | Intellia Therapeutics, Inc. (NTLA) | Director | Buy | 9,200 | $0 |
| 2025-06-18 | Intellia Therapeutics, Inc. (NTLA) | Director | Buy | 8,000 | $0 |
Source: SEC Form 4 filings · as of 2026-06-10